Citi analyst Yigal Nochomovitz reiterated a Buy rating and $12.00 price target on Galera Therapeutics (NASDAQ: GRTX)Opens 90-Day Upside Catalyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE